Related Experiment Video
Updated: May 27, 2025
Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Neonatal Immunity to Candida: Current Understanding and Contributions of Murine Models
Angel Palacios1, Ajay Kumar2, Fides Myles C Caliwag3
1Universidad Autónoma de Nuevo León.
Insights
Neonatal candidiasis is a serious threat to infants due to their immature immune systems. Murine models help understand infant susceptibility and develop new Candida infection treatments.
Area of Science:
- Immunology
- Neonatal Medicine
- Infectious Diseases
Background:
- Neonatal candidiasis presents significant challenges, with infants being highly susceptible due to underdeveloped immune systems.
- Candida infections in newborns can range from mild to severe, potentially leading to systemic complications.
- The neonatal immune system exhibits a limited innate response and delayed adaptive immunity, increasing vulnerability.
Purpose of the Study:
- To review current research on the neonatal immune response to Candida infections.
- To highlight the critical role of murine models in understanding infant susceptibility.
- To provide insights for developing targeted treatments and preventive strategies.
Main Methods:
- Review of existing research findings on neonatal immunity and Candida.
- Analysis of data from murine models investigating immune cell functions and interactions.
- Examination of early-life Candida exposure effects on immune responses.
Main Results:
- Neonates possess a weaker innate and adaptive immune response, making them prone to Candida.
- Murine models are instrumental in dissecting the immune mechanisms underlying Candida susceptibility in infants.
- These models aid in understanding how early Candida exposure influences long-term immunity.
Conclusions:
- Understanding neonatal immune dynamics against Candida is crucial for improving infant health outcomes.
- Murine models provide valuable insights for developing effective therapeutic and preventive strategies.
- Targeted interventions are essential to combat neonatal candidiasis and reduce morbidity/mortality.
Abstract:
Neonatal candidiasis poses significant clinical challenges due to its potential for severe morbidity and mortality in vulnerable infants. Due to their underdeveloped immune system, neonates are at a higher risk for infections caused by Candida species. They can vary from mild to severe, including penetrating deep tissues, bloodstream spread, and dissemination to organs. The immune system of newborns is marked by a limited innate immune response, with lower levels of pro-inflammatory cytokines. Adaptive immunity, important for lasting protection, also experiences delayed maturation with weakened Th1 and Th17 responses. These shortcomings result in a higher vulnerability to Candida infections during infancy. Murine models have been crucial in understanding the reasons behind this susceptibility. These models assist in examining how different immune elements, like neutrophils, macrophages, and T cells, and their interactions are involved in Candida infections. Moreover, they offer an understanding of how early-life exposure to Candida affects immune responses and may aid in developing possible therapeutic plans. In this article we review current results from research to provide a thorough summary and critical insights into neonatal immune response to Candida, highlighting the importance of using murine models in this field of study. Understanding these immune dynamics is essential for creating specific treatments and preventive strategies to prevent newborns from Candida infections, ultimately improving neonatal health outcomes.
